CLENFENBRI Trademark
Trademark Overview
On Tuesday, February 28, 2023, a trademark application was filed for CLENFENBRI with the United States Patent and Trademark Office. The USPTO has given the CLENFENBRI trademark a serial number of 97816441. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, July 15, 2024. This trademark is owned by Merck Sharp & Dohme LLC. The CLENFENBRI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention and treatment of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of RSV; Pharmaceutical preparations for the prevention and treatment of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Pharmaceutical preparations, namely, anti-bacterials, antibiotics, anti-fungals, anti-infectives, anti-inflammatories, anti-parasitics, and antivirals; human vaccine preparations; Inhalers filled with pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders
General Information
| Serial Number | 97816441 |
| Word Mark | CLENFENBRI |
| Filing Date | Tuesday, February 28, 2023 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Monday, July 15, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 28, 2023 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of RSV; Pharmaceutical preparations for the prevention and treatment of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Pharmaceutical preparations, namely, anti-bacterials, antibiotics, anti-fungals, anti-infectives, anti-inflammatories, anti-parasitics, and antivirals; human vaccine preparations; Inhalers filled with pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 20, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Merck Sharp & Dohme LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Rahway, NJ 07065 |
| Party Name | Merck Sharp & Dohme LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Rahway, NJ 07065 |
Trademark Events
| Event Date | Event Description |
| Friday, March 3, 2023 | NEW APPLICATION ENTERED |
| Monday, March 20, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 24, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, October 25, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 8, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 28, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 28, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 23, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, July 15, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, July 15, 2024 | SOU EXTENSION 1 FILED |
| Monday, July 15, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, July 15, 2024 | SOU EXTENSION 1 GRANTED |
| Tuesday, December 10, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, December 10, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Thursday, December 12, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, December 12, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, December 12, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, December 12, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Tuesday, December 10, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, December 10, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, December 18, 2024 | SOU TEAS EXTENSION RECEIVED |
